Effects of intensive blood-pressure control in type 2 diabetes mellitus (Q34008161)

30 July 2017

title

Effects of intensive blood-pressure control in type 2 diabetes mellitus (English)

1 reference

30 July 2017

0 references

Kevin A Peterson

13

0 references

Hertzel C. Gerstein

Hertzel C Gerstein

17

0 references

John Buse

John B Buse

15

0 references

Faramarz Ismail-Beigi

18

Faramarz Ismail-Beigi

1 reference

30 July 2017

1

ACCORD Study Group

1 reference

30 July 2017

5

David C Goff

1 reference

30 July 2017

Denise G Simons-Morton

8

Denise G Simons-Morton

1 reference

30 July 2017

14

William T Friedewald

1 reference

30 July 2017

7

Jeffrey A Cutler

1 reference

30 July 2017

Jeffrey L Probstfield

11

Jeffrey L Probstfield

1 reference

30 July 2017

William C Cushman

2

1 reference

30 July 2017

Gregory W Evans

3

1 reference

30 July 2017

Robert P Byington

4

1 reference

30 July 2017

Richard H Grimm

6

1 reference

30 July 2017

Jan N Basile

9

1 reference

30 July 2017

Marshall A Corson

10

1 reference

30 July 2017

Lois Katz

12

1 reference

30 July 2017

J Thomas Bigger

16

1 reference

30 July 2017

language of work or name

English

0 references

publication date

14 March 2010

1 reference

The New England Journal of Medicine

30 July 2017

published in

1 reference

30 July 2017

volume

362

1 reference

30 July 2017

issue

17

1 reference

30 July 2017

page(s)

1575-1585

1 reference

Effects of combination lipid therapy in type 2 diabetes mellitus

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4123215

Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4123215

Effects of intensive glucose lowering in type 2 diabetes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4123215

Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4123215

Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4123215

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4123215

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4123215

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4123215

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4123215

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4123215

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4123215

Benefits and risks of more intensive blood pressure lowering in hypertensive patients of the HOT study with different risk profiles: does a J-shaped curve exist in smokers?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4123215

Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial: Design and Methods

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4123215

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial

29 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20228401

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20228401

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20228401

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1056/NEJMOA1001286

1 reference

30 July 2017

1 reference

30 July 2017

1 reference